About

Steve Dubin, J.D., has served on Adicet Bio's board since the completion of the merger and chairs the Audit Committee. Since November 2011 he has been a Principal in SDA Ventures LLC, a firm assisting emerging-growth and middle-market companies primarily in health, wellness and nutritional products.

From 2006 until Martek Biosciences was acquired by Royal DSM in February 2011 he served as Martek's CEO and a director; he later served as President of DSM's Nutritional Lipids Division and as a Senior Advisor to DSM Nutritional Products. He joined Martek in 1992 and held roles including CFO, Treasurer, Secretary, General Counsel and President. He is a CPA and a member of the Maryland Bar, with a bachelor's in accounting from the University of Maryland and a J.D. from George Washington University.

Roles

Adicet Bio, Inc.
Director · Current role
2020–present
Martek Biosciences Corporation
Chief Executive Officer & director · Led the company until its February 2011 acquisition by Royal DSM; joined in 1992 and served as President from 2003 to 2006 and earlier as CFO, Treasurer, Secretary and General Counsel.
2006-2011
Koninklijke DSM N.V. (DSM)
President, Nutritional Lipids Division; Senior Advisor · President of the Nutritional Lipids Division from February to October 2011, then Senior Advisor to DSM Nutritional Products through October 2012.
2011-2012
Alcresta Therapeutics, Inc.
Board member
2013-2024

External Roles

SDA Ventures LLC
Principal
Phytolon LTD
Board member
Exosomm LTD
Board member
Paine & Partners
Senior Advisor
UCAN Company
Board member

Director Compensation

FY 2025
Fees earned or paid in cash
$61,761
Stock awards
$4,630
Option awards
$15,715
Total
$82,106

Also at Adicet Bio, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

You're subscribed.

Thanks for signing up.